Company intelligence / Profile preview

北京天诚医药科技

Beijing, Beijing, China

Ownership: Private
Employees: ~41
Development stage: Other

Overview

Beijing Tiancheng Pharmaceutical Technology Co., Ltd. is a Chinese biopharmaceutical company and a core subsidiary of InnoCare Pharma. Established in 2015, the company specializes in the research, process development, pilot production, and commercial manufacturing of innovative small molecule and biologic therapeutics, primarily focusing on oncology and autoimmune diseases. It operates InnoCare's major anti-tumor innovative drug production base in Beijing's Future Science Park. The company's pipeline includes gunagratinib (ICP-192), a pan-FGFR inhibitor currently in Phase 2 clinical trials for cholangiocarcinoma and urothelial carcinoma, and ICP-105, an FGFR4 inhibitor in Phase 1 development for liver cancer. Additionally, Beijing Tiancheng Pharmaceutical Technology actively collaborates with academic institutions like Peking University to advance novel antibody and antibody-drug conjugate (ADC) platforms.

Therapeutic areas: Oncology
Modalities: Small moleculeAntibody-drug conjugateBiologicMonoclonal antibody
Industry: Biotech

Partnerships

Peking University Cancer HospitalPeking University Institute of Molecular Medicine

Beyond the preview

Go deeper on 北京天诚医药科技.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 北京天诚医药科技.

Explore the full profile